Tempus AI (TEM) shares are trading lower despite beating Q2 revenue and EPS expectations, as investors focus on a deceleration in revenue growth and a modest guidance raise. Technical indicators suggest a continued downtrend, with the stock trading below key moving averages and momentum fading.
Tempus AI reported Q2 earnings that technically beat analyst expectations for both revenue and EPS. However, the market is reacting negatively due to a perceived cooling of revenue growth compared to previous quarters and a guidance raise that was deemed modest. This has led to a 'reset in expectations' among traders, despite positive indicators like oncology volume growth. The stock's technical setup, including trading below all major SMAs and a 'death cross,' reinforces the bearish sentiment, suggesting that rallies are likely to be sold off. This indicates a short-term negative outlook for TEM, with the burden of proof on bulls to reverse the downtrend.